Bluebook
Diagnostics and Tools September 2023
2023 - September: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Gedi Cube was acquired by Renovaro Biosciences Inc. (NasdaqCM:RENB)
- Repligen Corporation (NasdaqGS:RGEN) announced its acquisition of Metenova AB
- Harbinger Health closed a $140MM Series A Financing, led by Flagship Pioneering